Turkey Diagnostics Imaging Market, By Type (X-Ray Imaging Solutions, Ultrasound Systems, MRI Systems, CT Scanners, Nuclear Imaging Solutions), By Mobility (Portable, Standalone), By Source (Domestic, Import), By Application (Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Gynecology, Others), By End User (Hospitals & Clinics, Diagnostic Centers, Ambulatory Care Centers, Others), By Region, Competition, Forecast & Opportunities, 2021-2031F

Key Insights	Details
Forecast Period	2027-2031
Market Size (2025)	USD 559.81 Million
CAGR (2026-2031)	3.98%
Fastest Growing Segment	MRI Systems
Largest Market	Marmara
Market Size (2031)	USD 707.52 Million

Market Overview

The Turkey Diagnostics Imaging Market will grow from USD 559.81 Million in 2025 to USD 707.52 Million by 2031 at a 3.98% CAGR. The Turkey Diagnostics Imaging Market encompasses medical technologies employed for visualizing the internal structures of the body to diagnose diseases, including modalities such as X-ray, magnetic resonance imaging, computed tomography, and ultrasound systems. Key growth drivers supporting this market include the increasing prevalence of chronic diseases requiring early and accurate diagnosis, substantial government investments in healthcare infrastructure through initiatives like city hospitals, and an expanding aging population with rising healthcare needs. According to the International Trade Administration, at the end of 2023, Turkey possessed 1,001 MRI scanners, 1,359 CT scanners, and 5,750 ultrasound machines in its healthcare facilities.

A significant challenge impeding market expansion is the high capital and operational costs associated with advanced diagnostic imaging equipment, which are predominantly sourced from international manufacturers. This dependency on imports exposes procurement costs to currency fluctuations and can limit access to cutting-edge technology, particularly for smaller healthcare providers.

Key Market Drivers

Rising Chronic Disease Burden Drives Imaging Demand
The increasing prevalence of chronic diseases significantly drives demand within the Turkey Diagnostics Imaging Market, as early and accurate diagnosis is crucial for effective patient management and treatment planning. Conditions such as cardiovascular diseases, diabetes, and various cancers necessitate advanced imaging modalities for screening, staging, and monitoring disease progression. According to the "Addressing Health Challenges in Türkiye" report, circulatory system diseases were responsible for 33.4% of all deaths in Turkey in 2023, underscoring the substantial burden of non-communicable diseases. This high prevalence fuels the continuous need for imaging services, pushing healthcare providers to invest in modern diagnostic equipment to meet the growing diagnostic requirements of the population.

Public Investment and Medical Tourism Drive Imaging Market Growth
Government healthcare initiatives and substantial infrastructure investments also provide a robust impetus to the market. These initiatives aim to enhance healthcare accessibility and quality across the nation, often involving the construction and equipping of new hospitals, including large-scale city hospitals. As reported by FrontierView in November 2023, Turkiye's Vice President Cevdet Yilmaz announced that TRY 1.65 trillion would be allocated to public healthcare expenditures in 2024, signaling significant government commitment to the sector. This public spending directly facilitates the procurement of advanced diagnostic imaging systems. Furthermore, the burgeoning medical tourism sector further stimulates market expansion; Turkey’s medical tourism sector reached $3 billion in 2024, according to an article published in December 2025 discussing Turkey's healthcare spending surge, boosting investments in state-of-the-art medical equipment for internationally accredited facilities to serve a growing number of international patients.

Download Free Sample Report

Key Market Challenges

High Capital Costs and Import Dependency Impeding Market Expansion
A significant challenge impeding the expansion of the Turkey Diagnostics Imaging Market is the high capital and operational costs associated with advanced diagnostic imaging equipment. These technologies are predominantly sourced from international manufacturers, establishing a substantial dependency on imports. This reliance directly exposes procurement costs to considerable currency fluctuations, which consequently elevate the overall investment necessary for obtaining and maintaining critical diagnostic systems.

Smaller Providers Affected and Budgeting Challenges Amid Lira Volatility
Such heightened expenditures disproportionately affect smaller healthcare providers, curtailing their capacity to invest in new or upgraded equipment and thus impeding the widespread adoption of modern diagnostic modalities throughout the nation. The persistent volatility of the Turkish Lira against major international currencies exacerbates this issue, making long-term budget planning for equipment acquisition exceptionally difficult for healthcare institutions. This financial pressure can lead to delayed technology upgrades and insufficient equipment inventories, ultimately restricting the market's organic growth and its ability to adequately address the rising demand for advanced diagnostic services effectively.

Key Market Trends

AI and Automation Driving Efficiency in Turkish Radiology Workflows
AI and automation integration in radiology workflows signifies a pivotal trend in the Turkey Diagnostics Imaging Market, driven by the imperative to enhance diagnostic efficiency and mitigate radiologist workload. These technologies expedite image analysis, improve detection of subtle abnormalities, and streamline operational processes for more accurate and timely diagnoses. The adoption of AI tools is transforming complex imaging data interpretation, enabling healthcare providers to manage increasing patient volumes. According to the 'Artificial Intelligence Adoption and Perspectives Among Turkish Radiologists: A National Survey', published in July 2025, 38.1% of Turkish radiologists surveyed had clinically utilized AI tools, indicating a growing embrace of these advanced solutions. This integration optimizes radiology departments, improving patient outcomes and resource allocation.

Localization of Imaging Equipment Bolstering Turkey's Supply Chain Resilience
Another crucial trend is the growing emphasis on domestic manufacturing and localization of imaging equipment within Turkey. This directly addresses the market's historical reliance on imported technologies, which exposes procurement costs to currency fluctuations and can hinder access for smaller healthcare entities. By fostering local production, Turkey aims to bolster supply chain resilience, reduce operational expenditures, and stimulate local innovation. Such initiatives are vital for enhancing national healthcare security and achieving greater self-sufficiency in medical technology. According to SEM Biotech, in June 2026, the share of domestically manufactured products in public medical device procurement in Turkey had increased from 24% to over 31%, underscoring significant progress in localization efforts. This strategic shift is expected to mitigate import dependency and stabilize equipment acquisition costs.

Segmental Insights

Drivers of MRI Growth in Turkey
The MRI Systems segment stands as the fastest-growing component within the Turkey Diagnostics Imaging Market, propelled by several key factors. This growth is primarily attributed to the rising prevalence of chronic conditions, such as neurological disorders, orthopedic issues, and cancer, which demand the high precision and excellent soft tissue contrast offered by MRI for effective diagnosis and monitoring. Concurrently, Turkey's aging population contributes to an increased demand for advanced diagnostic imaging to address age-related health challenges. Furthermore, strategic investments by Turkey's Ministry of Health in modernizing healthcare infrastructure, particularly within new city hospitals and tertiary referral centers, alongside favorable procurement policies facilitated by the Social Security Institution, are instrumental in expanding the deployment and utilization of MRI technology across the nation.

Regional Insights

Marmara's market leadership driven by demographics, infrastructure, and policy support.
The Marmara region dominates the Turkey Diagnostics Imaging Market primarily due to its significant demographic density and robust economic leadership. As Turkey's most populous and urbanized area, encompassing Istanbul and other major economic centers, it generates substantial patient volumes and heightened demand for diagnostic services. This concentration of population is supported by a mature and advanced healthcare infrastructure, featuring numerous private and public hospitals, as well as specialized diagnostic laboratories. Furthermore, the region functions as a crucial referral hub for regional healthcare networks and is a prominent destination for medical tourism, attracting a diverse patient base. The Turkish Ministry of Health's strategic investments in advanced medical imaging infrastructure, particularly within city hospitals and tertiary referral centers, often through public-private partnerships, along with favorable procurement policies from the Social Security Institution, further solidify Marmara's market leadership.

Recent Developments

• In November 2025, ASELSAN, a prominent Turkish technology company, secured its largest healthcare contract to date, valued at $26.1 million, for the procurement of medical imaging systems intended for domestic deployment. This significant agreement underscores ASELSAN's expanding commitment to medical technologies within the Turkey Diagnostics Imaging Market. The company's healthcare portfolio already includes domestically developed imaging devices, such as the Mobile Digital X-Ray Device (ADR-M100), which had been deployed at Hacettepe University Faculty of Medicine in 2024. This contract represents a substantial step towards reducing Turkey's reliance on imported medical imaging solutions and bolstering local production capabilities.
• In March 2025, Medicalgorithmics S.A., a medical technology firm, established a distribution partnership with the Turkish company Ege Aritmi. This collaboration marked Medicalgorithmics' entry into the Turkish market, expanding its presence for advanced medical devices, including diagnostic solutions. The agreement specifically aimed to introduce products such as AI-driven ambulatory ECG monitoring and sophisticated CT-based cardiac diagnostics software. This strategic move was expected to generate approximately PLN 1.5 million in annual revenue for Medicalgorithmics, leveraging Turkey's growing adoption of modern medical devices, particularly in imaging and diagnostics, and strengthening the local healthcare sector with new technological offerings.
• In February 2025, Neusoft Medical Systems unveiled its latest intelligent imaging solutions at Arab Health 2025, with a direct impact on the Turkey Diagnostics Imaging Market. The company officially launched its NeuViz Epoch+ CT, characterized as an ultra-fast wide-body computed tomography system, and the NeuEra Series PET/CT, described as a digitalized positron emission tomography/computed tomography system. These advanced diagnostic imaging modalities were introduced to the Middle East and Africa region, where Turkey serves as a significant market. The launch aimed to enhance diagnostic capabilities in Turkish healthcare institutions by providing state-of-the-art imaging technology.
• In 2024, a report highlighted significant breakthrough research activities by healthcare startups in Turkey, particularly those focused on diagnostic imaging. These emerging companies were actively engaged in developing artificial intelligence (AI) solutions designed to improve the accuracy of radiological readings. This initiative positioned Turkey as a fertile ground for collaboration and technology transfer in advanced medical technologies. The funding received by numerous biotechnology and healthcare startups during that year underscored a growing ecosystem dedicated to innovation. These efforts are poised to enhance diagnostic precision and efficiency within the Turkey Diagnostics Imaging Market.

Key Market Players

• Siemens Healthineers AG
• GE HealthCare Technologies Inc.
• Koninklijke Philips N.V.
• Canon Medical Systems Corporation
• Fujifilm Holdings Corporation
• Samsung Medison Co., Ltd.
• Mindray Bio-Medical Electronics Co., Ltd.
• Esaote S.p.A.
• Hologic, Inc.
• Shimadzu Corporation

By Type	By Mobility	By Source	By Application	By End User	By Region
X-Ray Imaging Solutions Ultrasound Systems MRI Systems CT Scanners Nuclear Imaging Solutions	Portable Standalone	Domestic Import	Cardiology Oncology Neurology Orthopedics Gastroenterology Gynecology Others	Hospitals & Clinics Diagnostic Centers Ambulatory Care Centers Others	Marmara Central Anatolia Aegean Mediterranean Black Sea South-Eastern Anatolia Eastern Anatolia

Report Scope:

In this report, the Turkey Diagnostics Imaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Turkey Diagnostics Imaging Market, By Type:

• X-Ray Imaging Solutions
• Ultrasound Systems
• MRI Systems
• CT Scanners
• Nuclear Imaging Solutions

• Turkey Diagnostics Imaging Market, By Mobility:

• Portable
• Standalone

• Turkey Diagnostics Imaging Market, By Source:

• Domestic
• Import

• Turkey Diagnostics Imaging Market, By Application:

• Cardiology
• Oncology
• Neurology
• Orthopedics
• Gastroenterology
• Gynecology
• Others

• Turkey Diagnostics Imaging Market, By End User:

• Hospitals & Clinics
• Diagnostic Centers
• Ambulatory Care Centers
• Others

• Turkey Diagnostics Imaging Market, By Region:

• Marmara
• Central Anatolia
• Aegean
• Mediterranean
• Black Sea
• South-Eastern Anatolia
• Eastern Anatolia